EVERETT HISTORICAL / SHUTTERSTOCK.COM
Nearly three years after the introduction of the inter partes review, LSIPR explores its impact on the life sciences sector and asks whether it is creating a culture of ‘reverse trolling’.
Sometimes, a good tool can find itself in the wrong hands.
In September 2012, the America Invents Act (AIA) introduced the inter partes review (IPR), a quicker, more cost-effective way of challenging patents on the basis of prior art consisting of patents or printed publications.
The AIA patent reform was squarely aimed at curbing the activities of non-practising entities (NPEs), also known as ‘patent trolls’, which had made life unpredictable for innovators in the tech industry.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
inter-partes review, AIA, NPEs, IPR, US Court of Appeals for the Federal Circuit, patent troll,